All news from Anaesthesiology

Lyme Disease Patients Vent Frustration During HHS Panel

Individuals with Lyme disease expressed frustration and anger about what they called the scientific and medical community's lack of seriousness and compassion about their illness, and delivered a wish list of prevention, treatment, and research priorities to a new federal committee charged with taking on the government's response to tick-borne disease.

Immune System can be Harnessed to Treat Cancer

According to new research published in Cell, chemicals that attract specialized immune cells toward tumours could be used to develop better immunotherapies for cancer patients. The study findings reveal a cellular and molecular checkpoint for intratumoral cDC1 recruitment that is targeted by tumour-derived PGE2 for immune evasion and that could be exploited for cancer therapy.

USFDA Approved the Use of L-glutamine to Treat Sickle Cell Disease

According to a new study reported in The Lancet Haematology, the USFDA approved the use of L-glutamine for the treatment of patients aged 5 years and older with sickle cell disease, on the basis of the results of a randomised phase 3 clinical trial. The trial demonstrated that patients treated with L-glutamine for 48 weeks had reduced frequency and length of hospital visits for sickle cell pain crisis compared with patients treated with placebo.

Bio-markers For a Wide Range of Diseases identified

Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells. The new, highly sensitive Luminex Multiplex Glycan Array enables the kind of volume needed to establish associations between antibody levels in our blood to these complex sugars, or glycans, and conditions from cancer to autoimmune disease and dementia.